Search Results 141-150 of 16782 for primary sclerosing cholangitis

1. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   The purpose of this study is to learn more about volixibat for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to ...

2. Medical Research & Education - Mayo Clinic News Network

   Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...

3. A Study to Find Consensus in the Definition and Management of Dominant Strictures in Primary Sclerosing Cholangitis - Mayo Clinic

   A Study to Find Consensus in the Definition and Management of Dominant Strictures in Primary Sclerosing Cholangitis · Overview · Participation eligibility.

4. Factors related to jaundice and transplant-free survival in patients with PSC who receive endoscopic treatment - Mayo Clinic

   ... primary sclerosing cholangitis (PSC). However, ERCP has some associated risks, and not all patients with PSC will benefit from undergoing this procedure ...

5. Mayo Clinic researchers announce discoveries from largest genome-wide study of chronic liver disease

   Primary sclerosing cholangitis affects 1 in 10,000 individuals, with about 75 percent developing inflammatory bowel disease (IBD), most often in the form of ...

6. Medical Research & Education - Mayo Clinic News Network

   Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...

7. Study Investigating the Activity of Vidofludimus Calcium as a Treatment for Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   Study Investigating the Activity of Vidofludimus Calcium as a Treatment for Primary Sclerosing Cholangitis (PSC) · Overview · Participation eligibility.

8. A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis - Mayo Clinic

   A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis · Overview.

9. A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   The purpose of the trial is to assess whether treatment with DUR-928 has any effect on the treatment of Primary Sclerosing Cholangitis (PSC). This trial will ...

10. The Updated Natural History Model for Primary Biliary Cholangitis - Medical Professionals - Mayo Clinic

    In the following model, short-term survival probability of a patient with primary biliary cholangitis is estimated based on repeated observation.